Achieve Life Sciences added to Russell 2000 index
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Achieve Life Sciences Inc (ACHV)
Achieve Life Sciences Inc stock price live, this page displays NASDAQ ACHV stock exchange data. View the ACHV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Achieve Life Sciences Inc real time stock price chart below.
What Is the Achieve Life Sciences Inc Stock Price Today?
The Achieve Life Sciences Inc stock price today is 6.110.
What Is the Stock Symbol for Achieve Life Sciences Inc?
The stock symbol for Achieve Life Sciences Inc is "ACHV."
What Stock Exchange Does Achieve Life Sciences Inc Trade On?
Achieve Life Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Achieve Life Sciences Inc a Good Stock to Buy?
Determining whether Achieve Life Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACHV quote. (ISIN: US0044685008)
What Is the Achieve Life Sciences Inc Stock Price Today?
The Achieve Life Sciences Inc stock price today is 6.110.
What Is the Stock Symbol for Achieve Life Sciences Inc?
The stock symbol for Achieve Life Sciences Inc is "ACHV."
What Stock Exchange Does Achieve Life Sciences Inc Trade On?
Achieve Life Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Achieve Life Sciences Inc a Good Stock to Buy?
Determining whether Achieve Life Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ACHV quote. (ISIN: US0044685008)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.810
6.400
52 wk Range
2.371
7.110
ACHV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.8106.400
52 wk Range
2.3717.110
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ACHV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
13.800
Upside
+125.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Achieve Life Sciences added to Russell 2000 index
- Investing.com
- Achieve Life Sciences added to Russell 2000 index
- Investing.com
- Achieve Life Sciences added to Russell 2000 index
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.800
(+125.86% Upside)
Achieve Life Sciences Inc Earnings Call Summary for Q1/2026
- Achieve Life Sciences reported Q1 2026 EPS of -$0.19, beating forecast of -$0.43 by 55.81%; stock rose 6.62% in pre-market trading to $5.96.
- Company secured $180 million in upfront capital to strengthen financial position and support broader commercial strategy execution.
- Plans to resubmit NDA in Q4 2026 for cytisinicline smoking cessation treatment, with commercial launch anticipated in H1 2027.
- CEO Dr. Andrew Goldberg emphasized strong financial position enables execution of commercial strategy for underserved cessation market.
- Key risks include potential regulatory delays from manufacturing transitions and ongoing negative EPS despite operational improvements.
Last Updated: 2026-05-14, 11:24 p/m
Read Full TranscriptEarnings
Latest Release
May 12, 2026
EPS / Forecast
-0.19 / -0.43
Revenue / Forecast
-- / --
Compare ACHV to Peers and Sector
Metrics to compare | ACHV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACHVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.1x | −3.7x | −0.4x | |
PEG Ratio | −0.62 | −0.05 | 0.00 | |
Price/Book | 58.7x | 2.8x | 2.6x | |
Price / LTM Sales | - | 91.7x | 3.0x | |
Upside (Analyst Target) | 96.4% | 122.6% | 51.5% | |
Fair Value Upside | Unlock | 2.7% | 8.8% | Unlock |
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Achieve Life Sciences (ACHV) Stock Price Today?
The Achieve Life Sciences stock price today is 6.110 USD.
What Stock Exchange Does Achieve Life Sciences Trade On?
Achieve Life Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Achieve Life Sciences?
The stock symbol for Achieve Life Sciences is "ACHV."
What Is the Achieve Life Sciences Market Cap?
As of today, Achieve Life Sciences market cap is 627.250M USD.
What Is Achieve Life Sciences's Earnings Per Share (TTM)?
The Achieve Life Sciences EPS (TTM) is -1.077.
When Is the Next Achieve Life Sciences Earnings Date?
Achieve Life Sciences will release its next earnings report on Aug 06, 2026.
From a Technical Analysis Perspective, Is ACHV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Achieve Life Sciences Stock Split?
Achieve Life Sciences has split 4 times.
How Many Employees Does Achieve Life Sciences Have?
Achieve Life Sciences has 28 employees.
What is the current trading status of Achieve Life Sciences (ACHV)?
As of Jul 13, 2026, Achieve Life Sciences (ACHV) is trading at a price of 6.110 USD, with a previous close of 6.400 USD. The stock has fluctuated within a day range of 5.810 USD to 6.400 USD, while its 52-week range spans from 2.371 USD to 7.110 USD.
What Is Achieve Life Sciences (ACHV) Price Target According to Analysts?
The average 12-month price target for Achieve Life Sciences is 13.800 USD, with a high estimate of 21 USD and a low estimate of 9 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +125.86% Upside potential.
What Is the ACHV Premarket Price?
ACHV's last pre-market stock price is 6.420 USD. The pre-market share volume is 5,120.000, and the stock has decreased by 0.020, or 0.310%.
What Is the ACHV After Hours Price?
ACHV's last after hours stock price is 6.020 USD, the stock has decreased by -0.090, or -1.470%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.